COVID-19 Impact on Non-Invasive Prenatal Testing Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Non-Invasive Prenatal Testing, including the following market information:
Major competitors identified in this market include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina, Berry Genomics, etc.
Based on the Region:
- Global Non-Invasive Prenatal Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Non-Invasive Prenatal Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Non-Invasive Prenatal Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Non-Invasive Prenatal Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina, Berry Genomics, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- High & Average Risk
- Low Risk
- 0-12 weeks
- 13-24 weeks
- 25-36 weeks
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Non-Invasive Prenatal Testing Industry
1.7 COVID-19 Impact: Non-Invasive Prenatal Testing Market Trends
2 GLOBAL NON-INVASIVE PRENATAL TESTING QUARTERLY MARKET SIZE ANALYSIS
2.1 Non-Invasive Prenatal Testing Business Impact Assessment - COVID-19
2.1.1 Global Non-Invasive Prenatal Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Non-Invasive Prenatal Testing Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Non-Invasive Prenatal Testing Quarterly Market Size, 2019 VS 2020
3.2 By Players, Non-Invasive Prenatal Testing Headquarters and Area Served
3.3 Date of Key Players Enter into Non-Invasive Prenatal Testing Market
3.4 Key Players Non-Invasive Prenatal Testing Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NON-INVASIVE PRENATAL TESTING SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 High & Average Risk
1.4.2 Low Risk
4.2 By Type, Global Non-Invasive Prenatal Testing Market Size, 2019-2021
5 IMPACT OF COVID-19 ON NON-INVASIVE PRENATAL TESTING SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 0-12 weeks
5.5.2 13-24 weeks
5.5.3 25-36 weeks
5.2 By Application, Global Non-Invasive Prenatal Testing Market Size, 2019-2021
5.2.1 By Application, Global Non-Invasive Prenatal Testing Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Sequenom
7.1.1 Sequenom Business Overview
7.1.2 Sequenom Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.1.3 Sequenom Non-Invasive Prenatal Testing Product Introduction
7.1.4 Sequenom Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.2.3 Roche Non-Invasive Prenatal Testing Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Natera
7.3.1 Natera Business Overview
7.3.2 Natera Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.3.3 Natera Non-Invasive Prenatal Testing Product Introduction
7.3.4 Natera Response to COVID-19 and Related Developments
7.4 LabCorp
7.4.1 LabCorp Business Overview
7.4.2 LabCorp Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.4.3 LabCorp Non-Invasive Prenatal Testing Product Introduction
7.4.4 LabCorp Response to COVID-19 and Related Developments
7.5 BGI Genomics
7.5.1 BGI Genomics Business Overview
7.5.2 BGI Genomics Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.5.3 BGI Genomics Non-Invasive Prenatal Testing Product Introduction
7.5.4 BGI Genomics Response to COVID-19 and Related Developments
7.6 Quest Diagnostics
7.6.1 Quest Diagnostics Business Overview
7.6.2 Quest Diagnostics Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Product Introduction
7.6.4 Quest Diagnostics Response to COVID-19 and Related Developments
7.7 Illumina
7.7.1 Illumina Business Overview
7.7.2 Illumina Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.7.3 Illumina Non-Invasive Prenatal Testing Product Introduction
7.7.4 Illumina Response to COVID-19 and Related Developments
7.8 Berry Genomics
7.8.1 Berry Genomics Business Overview
7.8.2 Berry Genomics Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.8.3 Berry Genomics Non-Invasive Prenatal Testing Product Introduction
7.8.4 Berry Genomics Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Non-Invasive Prenatal Testing Industry
1.7 COVID-19 Impact: Non-Invasive Prenatal Testing Market Trends
2 GLOBAL NON-INVASIVE PRENATAL TESTING QUARTERLY MARKET SIZE ANALYSIS
2.1 Non-Invasive Prenatal Testing Business Impact Assessment - COVID-19
2.1.1 Global Non-Invasive Prenatal Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Non-Invasive Prenatal Testing Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Non-Invasive Prenatal Testing Quarterly Market Size, 2019 VS 2020
3.2 By Players, Non-Invasive Prenatal Testing Headquarters and Area Served
3.3 Date of Key Players Enter into Non-Invasive Prenatal Testing Market
3.4 Key Players Non-Invasive Prenatal Testing Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON NON-INVASIVE PRENATAL TESTING SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 High & Average Risk
1.4.2 Low Risk
4.2 By Type, Global Non-Invasive Prenatal Testing Market Size, 2019-2021
5 IMPACT OF COVID-19 ON NON-INVASIVE PRENATAL TESTING SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 0-12 weeks
5.5.2 13-24 weeks
5.5.3 25-36 weeks
5.2 By Application, Global Non-Invasive Prenatal Testing Market Size, 2019-2021
5.2.1 By Application, Global Non-Invasive Prenatal Testing Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Sequenom
7.1.1 Sequenom Business Overview
7.1.2 Sequenom Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.1.3 Sequenom Non-Invasive Prenatal Testing Product Introduction
7.1.4 Sequenom Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.2.3 Roche Non-Invasive Prenatal Testing Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Natera
7.3.1 Natera Business Overview
7.3.2 Natera Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.3.3 Natera Non-Invasive Prenatal Testing Product Introduction
7.3.4 Natera Response to COVID-19 and Related Developments
7.4 LabCorp
7.4.1 LabCorp Business Overview
7.4.2 LabCorp Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.4.3 LabCorp Non-Invasive Prenatal Testing Product Introduction
7.4.4 LabCorp Response to COVID-19 and Related Developments
7.5 BGI Genomics
7.5.1 BGI Genomics Business Overview
7.5.2 BGI Genomics Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.5.3 BGI Genomics Non-Invasive Prenatal Testing Product Introduction
7.5.4 BGI Genomics Response to COVID-19 and Related Developments
7.6 Quest Diagnostics
7.6.1 Quest Diagnostics Business Overview
7.6.2 Quest Diagnostics Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Product Introduction
7.6.4 Quest Diagnostics Response to COVID-19 and Related Developments
7.7 Illumina
7.7.1 Illumina Business Overview
7.7.2 Illumina Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.7.3 Illumina Non-Invasive Prenatal Testing Product Introduction
7.7.4 Illumina Response to COVID-19 and Related Developments
7.8 Berry Genomics
7.8.1 Berry Genomics Business Overview
7.8.2 Berry Genomics Non-Invasive Prenatal Testing Quarterly Revenue, 2020
7.8.3 Berry Genomics Non-Invasive Prenatal Testing Product Introduction
7.8.4 Berry Genomics Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Non-Invasive Prenatal Testing Assessment
Table 9. COVID-19 Impact: Non-Invasive Prenatal Testing Market Trends
Table 10. COVID-19 Impact Global Non-Invasive Prenatal Testing Market Size
Table 11. Global Non-Invasive Prenatal Testing Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Non-Invasive Prenatal Testing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Non-Invasive Prenatal Testing Market Growth Drivers
Table 14. Global Non-Invasive Prenatal Testing Market Restraints
Table 15. Global Non-Invasive Prenatal Testing Market Opportunities
Table 16. Global Non-Invasive Prenatal Testing Market Challenges
Table 17. By Players, Non-Invasive Prenatal Testing Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Non-Invasive Prenatal Testing Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Non-Invasive Prenatal Testing Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Non-Invasive Prenatal Testing Market
Table 21. Key Players Non-Invasive Prenatal Testing Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Non-Invasive Prenatal Testing Market Size 2019-2021, (US$ Million)
Table 24. Global Non-Invasive Prenatal Testing Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Non-Invasive Prenatal Testing Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 57. Sequenom Business Overview
Table 58. Sequenom Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Sequenom Non-Invasive Prenatal Testing Product
Table 60. Sequenom Response to COVID-19 and Related Developments
Table 61. Roche Business Overview
Table 62. Roche Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Non-Invasive Prenatal Testing Product
Table 64. Roche Response to COVID-19 and Related Developments
Table 65. Natera Business Overview
Table 66. Natera Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Natera Non-Invasive Prenatal Testing Product
Table 68. Natera Response to COVID-19 and Related Developments
Table 69. LabCorp Business Overview
Table 70. LabCorp Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. LabCorp Non-Invasive Prenatal Testing Product
Table 72. LabCorp Response to COVID-19 and Related Developments
Table 73. BGI Genomics Business Overview
Table 74. BGI Genomics Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. BGI Genomics Non-Invasive Prenatal Testing Product
Table 76. BGI Genomics Response to COVID-19 and Related Developments
Table 77. Quest Diagnostics Business Overview
Table 78. Quest Diagnostics Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Quest Diagnostics Non-Invasive Prenatal Testing Product
Table 80. Quest Diagnostics Response to COVID-19 and Related Developments
Table 81. Illumina Business Overview
Table 82. Illumina Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Illumina Non-Invasive Prenatal Testing Product
Table 84. Illumina Response to COVID-19 and Related Developments
Table 85. Berry Genomics Business Overview
Table 86. Berry Genomics Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Berry Genomics Non-Invasive Prenatal Testing Product
Table 88. Berry Genomics Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Non-Invasive Prenatal Testing Assessment
Table 9. COVID-19 Impact: Non-Invasive Prenatal Testing Market Trends
Table 10. COVID-19 Impact Global Non-Invasive Prenatal Testing Market Size
Table 11. Global Non-Invasive Prenatal Testing Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Non-Invasive Prenatal Testing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Non-Invasive Prenatal Testing Market Growth Drivers
Table 14. Global Non-Invasive Prenatal Testing Market Restraints
Table 15. Global Non-Invasive Prenatal Testing Market Opportunities
Table 16. Global Non-Invasive Prenatal Testing Market Challenges
Table 17. By Players, Non-Invasive Prenatal Testing Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Non-Invasive Prenatal Testing Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Non-Invasive Prenatal Testing Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Non-Invasive Prenatal Testing Market
Table 21. Key Players Non-Invasive Prenatal Testing Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Non-Invasive Prenatal Testing Market Size 2019-2021, (US$ Million)
Table 24. Global Non-Invasive Prenatal Testing Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Non-Invasive Prenatal Testing Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Non-Invasive Prenatal Testing Market Size, 2019-2021 (US$ Million)
Table 57. Sequenom Business Overview
Table 58. Sequenom Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Sequenom Non-Invasive Prenatal Testing Product
Table 60. Sequenom Response to COVID-19 and Related Developments
Table 61. Roche Business Overview
Table 62. Roche Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Non-Invasive Prenatal Testing Product
Table 64. Roche Response to COVID-19 and Related Developments
Table 65. Natera Business Overview
Table 66. Natera Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Natera Non-Invasive Prenatal Testing Product
Table 68. Natera Response to COVID-19 and Related Developments
Table 69. LabCorp Business Overview
Table 70. LabCorp Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. LabCorp Non-Invasive Prenatal Testing Product
Table 72. LabCorp Response to COVID-19 and Related Developments
Table 73. BGI Genomics Business Overview
Table 74. BGI Genomics Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. BGI Genomics Non-Invasive Prenatal Testing Product
Table 76. BGI Genomics Response to COVID-19 and Related Developments
Table 77. Quest Diagnostics Business Overview
Table 78. Quest Diagnostics Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Quest Diagnostics Non-Invasive Prenatal Testing Product
Table 80. Quest Diagnostics Response to COVID-19 and Related Developments
Table 81. Illumina Business Overview
Table 82. Illumina Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Illumina Non-Invasive Prenatal Testing Product
Table 84. Illumina Response to COVID-19 and Related Developments
Table 85. Berry Genomics Business Overview
Table 86. Berry Genomics Non-Invasive Prenatal Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Berry Genomics Non-Invasive Prenatal Testing Product
Table 88. Berry Genomics Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Non-Invasive Prenatal Testing Product Picture
Figure 2. Non-Invasive Prenatal Testing Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Non-Invasive Prenatal Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Non-Invasive Prenatal Testing Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Non-Invasive Prenatal Testing Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Non-Invasive Prenatal Testing Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Non-Invasive Prenatal Testing Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Non-Invasive Prenatal Testing Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Non-Invasive Prenatal Testing Market Size Market Share, 2019-2021
Figure 1. Non-Invasive Prenatal Testing Product Picture
Figure 2. Non-Invasive Prenatal Testing Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Non-Invasive Prenatal Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Non-Invasive Prenatal Testing Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Non-Invasive Prenatal Testing Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Non-Invasive Prenatal Testing Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Non-Invasive Prenatal Testing Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Non-Invasive Prenatal Testing Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Non-Invasive Prenatal Testing Market Size Market Share, 2019-2021
